Google+ data security updates

Google+ data leak will the platform be closed, after more user data is open.
This news has been confirmed by Google through a blog post.An API update will be
made for the service G +, from Google, there is no user data that is misused
or also password leaks or user data that uses the details directly.

But there are concerns that theoretically malicious users can use details
to trick the original user into submitting details.

Data that may leak may include real name, age, and email address. Even if users

have set their profile to private, they will still be affected.

Since the news was broadcast on Monday December 10, leading publications have
reminded users that companies like Google will never ask for personal details
via email and we must remember and be careful about this.

What does Google say?

David Thacker, vice president of Product Management in G Suite, published
a blog post entitled 'Speeding up changes to Google+'.

It read: "In October, we announced that we would enjoy the consumer version
of Google+ and API because of the significant challenges involved in maintaining
successful products that meet consumer expectations, and low platform usage.

"We recently decided that some users were affected by software updates introduced
 in November that contained bugs that affected the Google+ API.

"We found this bug as part of our standard and continuous testing procedures and
corrected it within a week after it was introduced."


The statement, in an effort to convince users, continued: "There is no third
party that jeopardizes our system, and we have no evidence that application developers
who accidentally have this access for six days know or abuse it in any way."

"With the discovery of this new bug, we have decided to accelerate the termination
of all Google+ APIs; this will happen in the next 90 days. "He added: "We have also
decided to accelerate Google+ consumer sunsetting from August 2019 to April 2019.
While we realize there are implications for developers, we want to ensure the
protection of our users."

Hopefully the system will return to healthier and users will be more comfortable
using this G+ platform without worrying about data leakage issues

Pythons caught when eel fishing

in the BBC News Indonesia, the python caught the incident
on November 22, in the village of Pucuang Anam, Pariaman, West Sumatra, the community
report the AFP News Agency.

the capture process is very difficult because the python has rebelled
villagers who were looking for eels, initially thought the snake was crossing on a
the small river flow was thought to be an old wooden shell. But after a citizen
touch it, the snake moves, makes people panic.

After successfully conquering it, residents contacted Pariaman zoo,
but the zoo refuses to accommodate it because it has excess animal inhabitants,
AFP reports.


Finally the residents of Pucuang Anam made a large cage for the giant snake's place

A cyclist almost got hit by a passing train

a cyclist has broken through the crossing of a train crossing without a guard and he is trying as fast as possible to avoid it which incident makes him in danger, this happened in the Netherland

news source: CNN

Lamborghini Drift VS Ford Mustang

You must be interested and want to see because it's really cool for me, what do you think?

https://www.youtube.com

Imagine lambo against which mustang wins? But that is not the important thing that is beneficial here is attractive and entertaining, the muscle car supercar which includes the latest production

Ford Mustang RTR 550 5.0L V-8 rider Vaughn Gittin Jr.

Lamborghini 650 HP V-12 driver Daigo Saito's

Both of which are built specifically to float how their own strength and speed

Lamborghini Daigo Saito is claimed to be the first lambo built specifically for driftracing

Amyotrophic lateral sclerosis (ALS) what is this?

Amyotrophic lateral sclerosis (ALS), also known as motor neurone disease (MND), or Lou Gehrig's 

disease, is a specific disease that causes the death of neurons that control voluntary muscles.




Some also use the term motor neuron disease for a group of conditions where ALS is the most common.


 

ALS is characterized by stiff muscles, twitching of the muscles, and the muscles gradually diminish in 


size so that it can cause difficulty speaking, swallowing, and finally breathing. 


 


the cause is largely unknown and between 5-10% of cases are inherited from one's parents. half of these 


genetic cases are caused by one of two specific genes. Research and testing is still done in depth

there is no cure for ALS. Only a drug called riluzole can extend the life of about two to three months. 


This disease can affect people of all ages, but usually begins around the age of 60 years and in inherited


 cases it is estimated to start around the age of 50 years and the average survival from sufferers to death 


is two to four years. About 10% survive more than 10 years. Most die from respiratory failure. In most


parts of the world, the level of ALS is unknown. In Europe and the United States, this disease attacks


around two to three people per 100,000 per year.


 

Disease described in 1824 by Charles Bellyang in 1874 began to be known as amyotrophic lateral 


sclerosis. It became famous in the United States in the 20th century when in 1939 baseball player 


Lou Gehrig had been exposed to ALS and then knew many people in the world

ALS is a motor neuron disease, also spelled "motor neuron disease", which is a group of neurological 


disorders that selectively affect motor neurons








about 1% of all cases begin before age 25 and sufferers tend to be male,







 




 Signs and symptoms This disorder causes muscle weakness, atrophy, and muscle spasms throughout




 the body due to upper motor degeneration and lower motor neurons then Individuals affected by this 



disorder eventually lose the ability to start and control all motor movements and functions of the 



bladder and intestines and extraocular muscles (muscles for move the eyesCognitive or behavioral



 dysfunction occurs in 30-50% of patients with ALS.